BD FocalPoint™ Slide Profiler vs. Manual Review

BD SurePath™ Pap test combined with the scrutiny of the BD FocalPoint™ Slide Profiler helps improve the accuracy of the Pap result.
The BD SurePath™ 13mm cell deposition area is the smallest viewing area of any Pap test on the market today. A reduced screening area enables your lab to be more efficient in reading slides and increasing turn-around times.
The BD SurePath™ proprietary Cell Enrichment process improves the ratio of diagnostic cells to non-diagnostic debris1, enabling a clear view for slide classification.
The BD FocalPoint™ Slide Profiler high throughput scanning improves lab processing capacity up to 33%.2	BD FocalPoint™ Slide Profiler Demonstrated 2: Numerically more HSIL+ slides for both BD SurePath™ liquid-based Pap test and conventional slides as compared to the current practice in clinical trials. 16% reduction in false-positives and a reduction in false-negatives on conventional slides. Statistically improved LSIL+ disease detection on conventional slides. Click here to see a figure of BD FocalPoint™ screening versus manual review.
The BD FocalPoint™ Slide Profiler improves lab throughput by archiving for No Further Review (NFR) up to 25% of the qualified slides not requiring manual Cytologist review.
The BD SurePath™ Pap test is the only Pap test available today that with a 64.4% increase in HSIL+ detection3.
The BD FocalPoint™ Slide Profiler directs cytotechnologist’s attention to slides most likely to contain abnormality, improving disease detection over manual review.2
BD SurePath™ liquid-based Pap test

Try the BD SurePath™ process in your laboratory.
1	See BD PrepStain™ Summary of Safety and Effectiveness Data, Section (3) Process Qualification, Enrichment Studies.
2	See BD FocalPoint™ Product insert. Note: Site to site variations in performance are expected. Each lab must carefully monitor the quality of its work.
3	Compared to conventional Pap smear. See BD PrepStain™ product insert, direct to vial study population, Table 26, Table 15.
Note: Site to site variations in performance are expected. Each lab must carefully monitor quality of its work.